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AbstrAct We report a case of a 30-year-old woman with discoid lupus 
erythematosus (DLE) involving only a single lower eyelid. The diagnostic 
delay is explained by the unspecific clinical and histopathology picture 
and lack of specific changes in the first biopsy specimen taken. The diag-
nosis was based on later histological and immunological studies. Palpebral 
involvement has rarely been reported as the first and sole manifestation 
of the disease. 
KEy worDS: unilateral, lower eyelid, discoid lupus erythematosus
IntroDUCtIon
Systemic lupus erythematosus (SLE) is a multior-
gan autoimmune disease of unknown etiology with 
many clinical manifestations. The skin is involved in 
up to 85% of systemic lupus erythematosus (SLE) 
cases and may be the only organ involved in chronic 
cutaneous lupus erythematosus (CCLE) (1). Discoid 
lupus erythematosus (DLE) is the most common sub-
type of CCLE in clinical practice. It is characterized by 
chronic, scarring lesions mainly involving the face 
or neck, but also found elsewhere, mostly on sun 
exposed areas. Involvement of the scalp leading to 
scarring alopecia is very common in patients with 
DLE. The typical skin lesions can be diagnosed easily, 
although palpebral involvement as a sole manifesta-
tion is very rarely reported. With distribution above 
the neck, the so-called localized form of DLE can be 
separated from a disseminated DLE (DDLE) if present 
below the neck as well. In 1982, the diagnosis crite-
ria for SLE were published by the American College 
of Rheumatology (ACR), revised in 1997, and are cur-
rently used in clinical practice. Concerning cutaneous 
manifestations, the ACR criteria include malar rash, 
discoid rash, photosensitivity, and oral ulcers. DLE 
lesions are common in SLE; on the other hand, SLE 
may uncommonly develop in patients with CCLE. All 
patients should be diagnosed and treated at an early 
stage to avoid eyelid dysfunction resulting from scar-
ring, synechiae, trichiasis, entropion, and ectropion. 
A a case of a 30-year-old Caucasian woman with uni-
laterall discoid lupus erythematosus lesion on her left 
lower eyelid is presented. This case demonstrates the 
wide range of differential diagnoses in such cases. 
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CASE rEPort
A 30-year-old Caucasian woman presented with 
semi-annular plaque on her left lower eyelid. A well-
demarcated plaque with a raised erythematous bor-
der and whitish scales in the center was seen. In the 
peripheral zone slightly expressed follicular hyper-
keratosis with depression and atrophy were visible 
(Figure1, Figure 2). The eyelid rim was inflamed with 
loss of eyelashes. No further involvement of the skin 
and its appendages was seen. Subjectively, itching 
and oozing were reported by the patient, aggravated 
upon sun exposure.  
Six months earlier the patient had had a nodu-
lar lesion, 5 mm in diameter, involving the left lower 
eyelid rim. It was excised due to ulceration . The his-
topathological examination showed a picture of a 
chronic inflammatory process. Three months later it 
progressed into the large erythematous plaque ob-
served upon admission at our clinic. 
In the differential diagnosis, we discussed Lisch 
epithelial corneal dystrophy (LECD), Woringer-Kolopp 
disease, Jessner-Kanoff lymphocytic infiltration, pseu-
dolymphoma, cutaneous lymphoma, and necrobiosis 
lipoidica. Psoriasis, seborrheic and atopic dermatitis, 
polymorphic light eruption, lymphocytic infiltration, 
and superficial epithelial tumors were excluded due 
to the clinical and morphological characteristics of 
the localized lesion. Peripheral blood count, bio-
chemistry, kidney and renal function tests, and urine 
examination tests were within normal ranges. Anti-
nuclear antibodies were negative.
Upon admittance we did not have the original his-
topathological specimens, so we repeated the skin bi-
opsy. Routine staining revealed a thickened basal cell 
membrane, hyperkeratosis, and atrophy of the epi-
dermis (Figure 3). There was perivascular and periad-
nexal lymphocytic inflammatory infiltrate throughout 
the dermis (Figure 4). Immunohistopathology stains 
were positive for CD3(+),CD4(-) CD8(+), Bcl-2 (+), and 
CD20(+), so the immunomorphologic structure of 
the infiltrate did not allow diagnosing the process as 
reactive lymphocytic infiltration or T-cell lymphoma. 
The diagnosis of DLE was made based on the clinical 
picture and histopathological features. 
We started treatment with chloroquine phosphate 
500 mg daily, with a reduction of the dose to 250 mg 
daily in 2 weeks. Considering the risk of severe and 
sometimes irreversible toxicity, the patient under-
went initial (base line) and periodic ophthalmologic 
examinations. Topical therapy included tacrolimus 
0.1% ointment and sun protection cream. No ste-
roid cream was applied. Clinical signs improved in six 
Figure 1. Unilateral involvement of the left lower 
eyelid with madarosis.
Figure 2. Semi-anular erythematous plaque 
with scales and follicular plugging.
Figure 3. Histopathology of the eyelid lesion: Thick-
ened basal cell membrane, hyperkeratosis, and 
atrophy of the epidermis (hematoxylin and eosin; 
×100).
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weeks. The patient was examined every six months 
and and subsequent worsening was observed due to 
the poor compliance of sunscreen use instructions 
and outdoor work in a sunny area (Figure 5).
DISCUSSIon
The clinical spectrum of cutaneous lupus erythe-
matosus involves a wide range of conditions. The 
typical features of DLE include localized inflamma-
tory scarring lesions, mainly involving the face and/or 
the neck (2). Periocular involvement occurs uncom-
monly and may progress from eyelid erythema to 
scarring and madarosis (3). DLE may rarely present as 
periorbital erythema and edema (4). In our case, the 
disease was limited to the skin and the lesions had 
the appearance of DLE, including atrophy, scarring, 
and follicular plugging. Palpebral lesions may rarely 
be the presenting or sole manifestation of the dis-
ease (3), and lower eyelid involvement is seen in 6% 
of patients with chronic, cutaneous lupus erythema-
tosus (5). The spectrum of ocular manifestations and 
complications of LECD include meibomian gland dys-
function, blepharitis, trichiasis, madarosis, conjuncti-
vitis, chronic eyelid edema, and eyelid plaques. In our 
case the eyelid was the only skin area affected by the 
disease.
A large group of diseases should be considered 
in differential diagnosis of DLE, including psoriasis, 
seborrheic and atopic dermatitis, and polymorphic 
light eruption (7). DLE could be suspected in cases of 
therapy-resistant and persisting inflammatory eyelid 
lesions (8). The non-specific changes in our case re-
quire further investigation to exclude autoimmune 
and proliferative skin diseases. Reaching the right di-
agnosis might take different amount of time, but per-
forming a skin biopsy with routine histopathological 
and immunologic tests can definitively establish the 
diagnosis. Patients with widespread involvement of-
ten have hematologic and serologic abnormalities, 
are more likely to develop systemic lupus erythema-
tosus, and are more difficult to treat (2). Our patient 
had no laboratory and immunologic data indicating 
systemic involvement. 
There is a need for steroid-free topical treatment 
for LE. With the development of topical calcineurin 
inhibitors, tacrolimus and pimecrolimus, an alterna-
tive has become available (9). Our report suggests 
that every patient with persistent periorbital lesions 
should undergo histological and immunofluorescent 
evaluation, and DLE should be included in the differ-
ential diagnosis. Our patient continues to receive fol-
low-up examinations.
ConCLUSIon
We report unilateral palpebral involvement as a 
sole presentation of DLE. The wide clinical spectrum 
in patients with DLE shows us the high index of suspi-
cion necessary in reaching the correct diagnosis. 
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